How can doctors tell the difference between apathy from cognitive decline and clinical depression?
The key clinical distinction lies in emotional experience. Depression is defined by unhappiness, sadness, and often anhedonia — the inability to feel pleasure. Apathy caused by cognitive decline, by contrast, does not require any unhappiness at all: a patient can be completely content, even serene, while having entirely lost the drive to do anything. According to Masud Husain, neurologists rely primarily on detailed conversation with the patient — not on brain scans alone — to make this distinction.
Husain illustrates this with the case of a patient named David, who suffered two strokes in his deep basal ganglia — damage that was invisible on standard imaging and only detectable on high-resolution scans. After the strokes, David stopped doing everything: he lost his job, his housing stability deteriorated, and he no longer engaged with the world around him. Yet he reported no distress. He was content. That emotional neutrality is precisely what sets pure apathy apart from depression, and it is a distinction that a clinical conversation can reveal in ways that a scan cannot.
What is anhedonia?
Anhedonia is the inability to feel pleasure from activities that were previously enjoyable. It is a hallmark symptom of clinical depression, and its presence or absence is one of the primary markers neurologists use to differentiate depression from apathy in patients showing reduced motivation.
The distinction matters clinically because the two conditions have different underlying mechanisms and respond to different treatments. Husain notes that approximately one third of people with depression do not respond to serotonergic antidepressants — a significant proportion of treatment-resistant cases. In David's case, the correct diagnosis pointed toward the dopaminergic system: he was treated with Ropinirole, a dopamine agonist, and within three months had a new job and a new relationship. This episode on Listenly goes deep into how brain circuits connect motivation, behavior, and cognitive health.
"For David, the effort of putting the music systems together was not worth the reward of being able to listen to something pleasurable — and in David's case, very few things were worth the effort."— Masud Husain, Habits and Hustle, Episode 579
About Masud Husain
Masud Husain is widely recognized as one of the world's leading neurologists in the fields of memory, motivation, and cognitive decline. He co-leads the Dementia Research Group at Oxford University — the same institution where he himself studied — making his career a continuous deepening of expertise within one of the most respected research environments in neuroscience.
He also serves as editor-in-chief of Brain, one of the most influential and peer-reviewed journals in neurology, a role that positions him at the center of cutting-edge clinical and scientific debate in his field.
What distinguishes Husain's perspective is his decades-long commitment to studying real patients rather than relying solely on theoretical models. His research into the basal ganglia and the neural circuits governing motivation has produced findings with direct clinical implications — including the insight that apathy, not memory loss, is often the earliest detectable signal of cognitive decline. Research from his group at Oxford shows that people who develop apathy in older age have twice the chance of developing dementia within the next ten years compared to those with normal motivation levels.
His work on patients like David — whose profound loss of motivation stemmed from two microscopic strokes invisible on standard scans — exemplifies his approach: combining advanced imaging, careful clinical conversation, and a willingness to look beyond conventional diagnostic frameworks.
See also
What is the earliest sign of cognitive decline or dementia according to neuroscience research?
According to Dr. Husain, motivation loss — known clinically as apathy — often appears before memory problems in cognitive decline. People who develop apathy in older age have twice the chance of developing dementia in the next ten years compared to those with normal motivation levels.